MNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients

dc.contributor.authorMosab Nouraldein Mohammed Hamad
dc.date.accessioned2023-12-10T10:14:32Z
dc.date.available2023-12-10T10:14:32Z
dc.date.issued2020
dc.description.abstractCOVID.19 Pandemic is a real disaster facing the globe, and up to date its uncontrollable , due to absence of data about the real mechanism upon which this virus overcome immune system and induce lethal symptoms certainly among aged and those with low-level of immunity. MNAD hypothesis based protocol aimed to measure validity of combination Minocycline as antibiotic, N. acetyl cysteine as antioxidant, aspirin as anticoagulant and vitamin D as immune regulator to treat COVID.19 infection. This protocol opened and implemented by any institutions or health authority after permission of the corresponding author of it.
dc.identifier.issn2518-3222
dc.identifier.urihttps://ds.eaeu.edu.sd/handle/10.58971/756
dc.language.isoother
dc.publisherجامعة الشيخ عبدالله البدري
dc.titleMNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
SJBR511325-330FTRevised3.pdf
Size:
538.04 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Collections